The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
Open accessAbstract
Il1rl1 (also known as ST2) is a member of the IL-1 superfamily, and its only known ligand is IL-33. ST2 exists in two forms as splice variants: a soluble form (sST2), which acts as a decoy receptor, sequesters free IL-33, and does not signal, and a membrane-bound form (ST2), which activates the MyD88/NF-κB signaling pathway to enhance mast cell, Th2, regulatory T cell (Treg), and innate lymphoid cell type 2 functions. sST2 levels are increased in patients with active inflammatory bowel disease, acute cardiac and small bowel transplant allograft rejection, colon and gastric cancers, gut mucosal damage during viral infection, pulmonary disease, heart disease, and graft-versus-host disease. Recently, sST2 has been shown to be secreted by intestinal pro-inflammatory T cells during gut inflammation; on the contrary, protective ST2-expressing Tregs are decreased, implicating that ST2/IL-33 signaling may play an important role in intestinal disease. This review will focus on what is known on its signaling during various inflammatory disease states and highlight potential avenues to intervene in ST2/IL-33 signaling as treatment options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J.-I., Ohtani, M., Fujii, H., & Koyasu, S. (2010) · Nature · doi:10.1038/nature08636 · Cited by 1,992
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
Sabatine, M. S., Cannon, C. P., Gibson, C. M., López-Sendón, J. L., Montalescot, G., Theroux, P., Claeys, M. J., Cools, F., Hill, K. A., Skene, A. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050522 · Cited by 1,924
Bieber, T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra074081 · Cited by 1,780
Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli (2011) · PubMed · doi:10.1031/ni.2131 · Cited by 1,286
Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., & Stockinger, B. (2008) · Nature Immunology · doi:10.1038/ni.1659 · Cited by 1,213
Moussion, C., Ortega, N., & Girard, J.-P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003331 · Cited by 1,179 · cited 4×
“IL-33 is expressed mainly by non-hematopoietic cells, including endothelial cells, adipocytes, fibroblasts, and intestinal and bronchial epithelial cells (8, 79, 80); however, some hematopoietic cells like dendritic cells (DCs) have also been show to express IL-33 when activated (5).”
BackgroundInfluentialMjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166 · cited 1×
“In humans ST2+, ILC2s were later found in the lung and gut (111), and these ILC2s produced IL-5 and IL-13.”
BackgroundInterleukin-33 in health and disease
Liew, F. Y., Girard, J.-P., & Turnquist, H. R. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.95 · Cited by 1,147
Systemically dispersed innate IL-13–expressing cells in type 2 immunity
Price, A. E., Liang, H.-E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J., & Locksley, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003988107 · Cited by 1,131
Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I.-C., et al. (2008) · Nature Immunology · doi:10.1038/ni.1677 · Cited by 1,122
Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
Lowes, M. A., Kikuchi, T., Fuentes-Duculan, J., Cardinale, I., Zaba, L. C., Haider, A. S., Bowman, E. P., & Krueger, J. G. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701213 · Cited by 1,082
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
Sanada, S., Hakuno, D., Higgins, L. J., Schreiter, E. R., McKenzie, A. N. J., & Lee, R. T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30634 · Cited by 1,044
The alarmin IL-33 promotes regulatory T-cell function in the intestine
Schiering, C., Krausgruber, T., Chomka, A., Fröhlich, A., Adelmann, K., Wohlfert, E. A., Pott, J., Griseri, T., Bollrath, J., Hegazy, A. N., et al. (2014) · Nature · doi:10.1038/nature13577 · Cited by 1,005
Disease-associated functions of IL-33: the new kid in the IL-1 family
Liew, F. Y., Pitman, N. I., & McInnes, I. B. (2010) · Nature Reviews Immunology · doi:10.1038/nri2692 · Cited by 1,003
A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
Salimi, M., Barlow, J. L., Saunders, S. P., Xue, L., Gutowska-Owsiak, D., Wang, X., Huang, L.-C., Johnson, D., Scanlon, S. T., McKenzie, A. N. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130351 · Cited by 979
Carriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606854104 · Cited by 966 · cited 6×
“Besides being secreted, IL-33 can be found in the nucleus of human high endothelial venules (7), lung airway epithelium, keratinocytes, fibroblastic reticular cells, and some epithelial cells of the stomach and salivary glands (8).”
BackgroundInfluentialKurowska-Stolarska, M., Stolarski, B., Kewin, P., Murphy, G., Corrigan, C. J., Ying, S., Pitman, N., Mirchandani, A., Rana, B., van Rooijen, N., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901575 · Cited by 717
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Cayrol, C., & Girard, J.-P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812690106 · Cited by 707
The development of inflammatory TH-17 cells requires interferon-regulatory factor 4
Brüstle, A., Heink, S., Huber, M., Rosenplänter, C., Stadelmann, C., Yu, P., Arpaia, E., Mak, T. W., Kamradt, T., & Lohoff, M. (2007) · Nature Immunology · doi:10.1038/ni1500 · Cited by 692
Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Lüthi, A. U., Cullen, S. P., McNeela, E. A., Duriez, P. J., Afonina, I. S., Sheridan, C., Brumatti, G., Taylor, R. C., Kersse, K., Vandenabeele, P., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.007 · Cited by 677
Weinberg, E. O., Shimpo, M., De Keulenaer, G. W., MacGillivray, C., Tominaga, S.-I., Solomon, S. D., Rouleau, J.-L., & Lee, R. T. (2002) · Circulation · doi:10.1161/01.cir.0000038705.69871.d9 · Cited by 645
IL-33 reduces the development of atherosclerosis
Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., & Liew, F. Y. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071868 · Cited by 642
The role of mast cells in allergic inflammation
Amin, K. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2011.09.007 · Cited by 641
Smithgall, M. D., Comeau, M. R., Park Yoon, B.-R., Kaufman, D., Armitage, R., & Smith, D. E. (2008) · International Immunology · doi:10.1093/intimm/dxn060 · Cited by 619
Löhning, M., Stroehmann, A., Coyle, A. J., Grogan, J. L., Lin, S., Gutierrez-Ramos, J.-C., Levinson, D., Radbruch, A., & Kamradt, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6930 · Cited by 605
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Lefrançais, E., Roga, S., Gautier, V., Gonzalez-de-Peredo, A., Monsarrat, B., Girard, J.-P., & Cayrol, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115884109 · Cited by 594
Chang, H.-C., Sehra, S., Goswami, R., Yao, W., Yu, Q., Stritesky, G. L., Jabeen, R., McKinley, C., Ahyi, A.-N., Han, L., et al. (2010) · Nature Immunology · doi:10.1038/ni.1867 · Cited by 577
Vasanthakumar, A., Moro, K., Xin, A., Liao, Y., Gloury, R., Kawamoto, S., Fagarasan, S., Mielke, L. A., Afshar-Sterle, S., Masters, S. L., et al. (2015) · Nature Immunology · doi:10.1038/ni.3085 · Cited by 555
Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells
Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B., Hoffmann, M., Ulges, A., Taube, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.07.014 · Cited by 554
Bartemes, K. R., Iijima, K., Kobayashi, T., Kephart, G. M., McKenzie, A. N., & Kita, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102832 · Cited by 549
Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation
Hayakawa, H., Hayakawa, M., Kume, A., & Tominaga, S.-I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704916200 · Cited by 546
Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells
Xu, D., Chan, W. L., Leung, B. P., Huang, F.-P., Wheeler, R., Piedrafita, D., Robinson, J. H., & Liew, F. Y. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.787 · Cited by 512
IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex
Chackerian, A. A., Oldham, E. R., Murphy, E. E., Schmitz, J., Pflanz, S., & Kastelein, R. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2551 · Cited by 508
Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker
Weinberg, E. O., Shimpo, M., Hurwitz, S., Tominaga, S.-I., Rouleau, J.-L., & Lee, R. T. (2003) · Circulation · doi:10.1161/01.cir.0000047274.66749.fe · Cited by 503
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
Mchedlidze, T., Waldner, M., Zopf, S., Walker, J., Rankin, A. L., Schuchmann, M., Voehringer, D., McKenzie, A. N. J., Neurath, M. F., Pflanz, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.018 · Cited by 502
A novel IL-1 family cytokine, IL-33, potently activates human eosinophils
Cherry, W. B., Yoon, J., Bartemes, K. R., Iijima, K., & Kita, H. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.04.005 · Cited by 499
Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection
Alves-Filho, J. C., Sônego, F., Souto, F. O., Freitas, A., Verri, W. A., Auxiliadora-Martins, M., Basile-Filho, A., McKenzie, A. N., Xu, D., Cunha, F. Q., et al. (2010) · Nature Medicine · doi:10.1038/nm.2156 · Cited by 486
An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation
Wilhelm, C., Hirota, K., Stieglitz, B., Van Snick, J., Tolaini, M., Lahl, K., Sparwasser, T., Helmby, H., & Stockinger, B. (2011) · Nature Immunology · doi:10.1038/ni.2133 · Cited by 481
Hunt, P. W., Sinclair, E., Rodriguez, B., Shive, C., Clagett, B., Funderburg, N., Robinson, J., Huang, Y., Epling, L., Martin, J. N., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu238 · Cited by 478
Kondo, Y., Yoshimoto, T., Yasuda, K., Futatsugi-Yumikura, S., Morimoto, M., Hayashi, N., Hoshino, T., Fujimoto, J., & Nakanishi, K. (2008) · International Immunology · doi:10.1093/intimm/dxn037 · Cited by 478
Pichery, M., Mirey, E., Mercier, P., Lefrancais, E., Dujardin, A., Ortega, N., & Girard, J.-P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101977 · Cited by 466
Kurowska-Stolarska, M., Kewin, P., Murphy, G., Russo, R. C., Stolarski, B., Garcia, C. C., Komai-Koma, M., Pitman, N., Li, Y., McKenzie, A. N. J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4780 · Cited by 460
Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells
Allakhverdi, Z., Smith, D. E., Comeau, M. R., & Delespesse, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2051 · Cited by 431
Imai, Y., Yasuda, K., Sakaguchi, Y., Haneda, T., Mizutani, H., Yoshimoto, T., Nakanishi, K., & Yamanishi, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307321110 · Cited by 431
Pecaric-Petkovic, T., Didichenko, S. A., Kaempfer, S., Spiegl, N., & Dahinden, C. A. (2009) · Blood · doi:10.1182/blood-2008-05-157818 · Cited by 420
The Alarmin Interleukin-33 Drives Protective Antiviral CD8 + T Cell Responses
Bonilla, W. V., Fröhlich, A., Senn, K., Kallert, S., Fernandez, M., Johnson, S., Kreutzfeldt, M., Hegazy, A. N., Schrick, C., Fallon, P. G., et al. (2012) · Science · doi:10.1126/science.1215418 · Cited by 417
IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells
Guo, L., Wei, G., Zhu, J., Liao, W., Leonard, W. J., Zhao, K., & Paul, W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906988106 · Cited by 417
IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes
Humphreys, N. E., Xu, D., Hepworth, M. R., Liew, F. Y., & Grencis, R. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2443 · Cited by 416
Pastorelli, L., Garg, R. R., Hoang, S. B., Spina, L., Mattioli, B., Scarpa, M., Fiocchi, C., Vecchi, M., & Pizarro, T. T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912678107 · Cited by 415
Shimpo, M., Morrow, D. A., Weinberg, E. O., Sabatine, M. S., Murphy, S. A., Antman, E. M., & Lee, R. T. (2004) · Circulation · doi:10.1161/01.cir.0000127958.21003.5a · Cited by 411
Gerlach, K., Hwang, Y., Nikolaev, A., Atreya, R., Dornhoff, H., Steiner, S., Lehr, H.-A., Wirtz, S., Vieth, M., Waisman, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2920 · Cited by 407
Ying, S., Humbert, M., Barkans, J., Corrigan, C. J., Pfister, R., Menz, G., Larché, M., Robinson, D. S., Durham, S. R., & Kay, A. B. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.7.3539 · Cited by 407
ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death
Vander Lugt, M. T., Braun, T. M., Hanash, S., Ritz, J., Ho, V. T., Antin, J. H., Zhang, Q., Wong, C.-H., Wang, H., Chin, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213299 · Cited by 405
Self-citationIL-33–activated dendritic cells induce an atypical TH2-type response
Rank, M. A., Kobayashi, T., Kozaki, H., Bartemes, K. R., Squillace, D. L., & Kita, H. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.026 · Cited by 399
IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors
Savinko, T., Matikainen, S., Saarialho-Kere, U., Lehto, M., Wang, G., Lehtimäki, S., Karisola, P., Reunala, T., Wolff, H., Lauerma, A., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.446 · Cited by 387
Tominaga, S.-I. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81679-5 · Cited by 385
Lefrançais, E., Duval, A., Mirey, E., Roga, S., Espinosa, E., Cayrol, C., & Girard, J.-P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410700111 · Cited by 384
Barlow, J. L., Peel, S., Fox, J., Panova, V., Hardman, C. S., Camelo, A., Bucks, C., Wu, X., Kane, C. M., Neill, D. R., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.012 · Cited by 383
Yagi, R., Zhong, C., Northrup, D. L., Yu, F., Bouladoux, N., Spencer, S., Hu, G., Barron, L., Sharma, S., Nakayama, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.012 · Cited by 379
Coyle, A. J., Lloyd, C., Tian, J., Nguyen, T., Erikkson, C., Wang, L., Ottoson, P., Persson, P., Delaney, T., Lehar, S., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.895 · Cited by 370
Seki, K., Sanada, S., Kudinova, A. Y., Steinhauser, M. L., Handa, V., Gannon;, J., & Lee, R. T. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.873240 · Cited by 365
Genome-wide Analyses of Transcription Factor GATA3-Mediated Gene Regulation in Distinct T Cell Types
Wei, G., Abraham, B. J., Yagi, R., Jothi, R., Cui, K., Sharma, S., Narlikar, L., Northrup, D. L., Tang, Q., Paul, W. E., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.007 · Cited by 337
Rengarajan, J., Mowen, K. A., McBride, K. D., Smith, E. D., Singh, H., & Glimcher, L. H. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011128 · Cited by 333
IL‐33‐activated dendritic cells are critical for allergic airway inflammation
Besnard, A., Togbe, D., Guillou, N., Erard, F., Quesniaux, V., & Ryffel, B. (2011) · European Journal of Immunology · doi:10.1002/eji.201041033 · Cited by 331
Bourgeois, E., Van, L. P., Samson, M., Diem, S., Barra, A., Roga, S., Gombert, J., Schneider, E., Dy, M., Gourdy, P., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838575 · Cited by 329
Jovanovic, I. P., Pejnovic, N. N., Radosavljevic, G. D., Pantic, J. M., Milovanovic, M. Z., Arsenijevic, N. N., & Lukic, M. L. (2014) · International Journal of Cancer · doi:10.1002/ijc.28481 · Cited by 328
Ali, S., Huber, M., Kollewe, C., Bischoff, S. C., Falk, W., & Martin, M. U. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705939104 · Cited by 325
Ali, S., Mohs, A., Thomas, M., Klare, J., Ross, R., Schmitz, M. L., & Martin, M. U. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003080 · Cited by 324
Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice
Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M., McKenzie, A. N., Xu, D., Sattar, N., McInnes, I. B., & Liew, F. Y. (2010) · Circulation Research · doi:10.1161/circresaha.110.218867 · Cited by 324
Depletion of fat-resident Treg cells prevents age-associated insulin resistance
Bapat, S. P., Myoung Suh, J., Fang, S., Liu, S., Zhang, Y., Cheng, A., Zhou, C., Liang, Y., LeBlanc, M., Liddle, C., et al. (2015) · Nature · doi:10.1038/nature16151 · Cited by 324
IL‐33 is a chemoattractant for human Th2 cells
Komai‐Koma, M., Xu, D., Li, Y., McKenzie, A. N. J., McInnes, I. B., & Liew, F. Y. (2007) · European Journal of Immunology · doi:10.1002/eji.200737547 · Cited by 319
An IL-1 Cytokine Member, IL-33, Induces Human Basophil Activation via Its ST2 Receptor
Suzukawa, M., Iikura, M., Koketsu, R., Nagase, H., Tamura, C., Komiya, A., Nakae, S., Matsushima, K., Ohta, K., Yamamoto, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5981 · Cited by 316
Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis
Palmer, G., Talabot‐Ayer, D., Lamacchia, C., Toy, D., Seemayer, C. A., Viatte, S., Finckh, A., Smith, D. E., & Gabay, C. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24305 · Cited by 313
Negishi, H., Fujita, Y., Yanai, H., Sakaguchi, S., Ouyang, X., Shinohara, M., Takayanagi, H., Ohba, Y., Taniguchi, T., & Honda, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607181103 · Cited by 310
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study
Levine, J. E., Braun, T. M., Harris, A. C., Holler, E., Taylor, A., Miller, H., Magenau, J., Weisdorf, D. J., Ho, V. T., Bolaños-Meade, J., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(14)00035-0 · Cited by 309
Bergers, G., Reikerstorfer, A., Braselmann, S., Graninger, P., & Busslinger, M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06367.x · Cited by 307
Jiang, H., Milovanović, M., Allan, D., Niedbala, W., Besnard, A., Fukada, S. Y., Alves‐Filho, J. C., Togbe, D., Goodyear, C. S., Linington, C., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201141947 · Cited by 307
IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation
Stolarski, B., Kurowska-Stolarska, M., Kewin, P., Xu, D., & Liew, F. Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000730 · Cited by 291
Hogan, S. P., Matthaei, K. I., Young, J. M., Koskinen, A., Young, I. G., & Foster, P. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1501 · Cited by 281
CD4+CD25bright T Cells in Human Intestinal Lamina Propria as Regulatory Cells
Makita, S., Kanai, T., Oshima, S., Uraushihara, K., Totsuka, T., Sawada, T., Nakamura, T., Koganei, K., Fukushima, T., & Watanabe, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3119 · Cited by 264
Asthma: pathogenesis and novel drugs for treatment
Olin, J. T., & Wechsler, M. E. (2014) · BMJ · doi:10.1136/bmj.g5517 · Cited by 256
Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage
Talabot-Ayer, D., Lamacchia, C., Gabay, C., & Palmer, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901744200 · Cited by 252
Turnquist, H. R., Zhao, Z., Rosborough, B. R., Liu, Q., Castellaneta, A., Isse, K., Wang, Z., Lang, M., Beer Stolz, D., Zheng, X. X., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100519 · Cited by 245
Gao, X., Wang, X., Yang, Q., Zhao, X., Wen, W., Li, G., Lu, J., Qin, W., Qi, Y., Xie, F., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401344 · Cited by 242
Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease
Beltrán, C. J., Núñez, L. E., Díaz-Jiménez, D., Farfan, N., Candia, E., Heine, C., López, F., González, M. J., Quera, R., & Hermoso, M. A. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21175 · Cited by 238
The Pathophysiology of Acute Graft-versus-Host Disease
Ferrara, J. L. M., Cooke, K. R., & Teshima, T. (2003) · International Journal of Hematology · doi:10.1007/bf02983793 · Cited by 235
Moritz, D. R., Rodewald, H.-R., Gheyselinck, J., & Klemenz, R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4866 · Cited by 233
Iwahana, H., Yanagisawa, K., Ito‐Kosaka, A., Kuroiwa, K., Tago, K., Komatsu, N., Katashima, R., Itakura, M., & Tominaga, S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00615.x · Cited by 232
IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing
Rak, G. D., Osborne, L. C., Siracusa, M. C., Kim, B. S., Wang, K., Bayat, A., Artis, D., & Volk, S. W. (2016) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.406 · Cited by 228
Kearley, J., Buckland, K. F., Mathie, S. A., & Lloyd, C. M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200805-666oc · Cited by 227
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival
Hartwell, M. J., Özbek, U., Holler, E., Renteria, A. S., Major-Monfried, H., Reddy, P., Aziz, M., Hogan, W. J., Ayuk, F., Efebera, Y. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89798 · Cited by 225
Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T., & Tominaga, S.-I. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81333-u · Cited by 219
Matta, B. M., Lott, J. M., Mathews, L. R., Liu, Q., Rosborough, B. R., Blazar, B. R., & Turnquist, H. R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400481 · Cited by 216
Sedhom, M. A. K., Pichery, M., Murdoch, J. R., Foligné, B., Ortega, N., Normand, S., Mertz, K., Sanmugalingam, D., Brault, L., Grandjean, T., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301785 · Cited by 210
Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils
Suzukawa, M., Koketsu, R., Iikura, M., Nakae, S., Matsumoto, K., Nagase, H., Saito, H., Matsushima, K., Ohta, K., Yamamoto, K., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.82 · Cited by 205
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival
Hartwell, M. J., Özbek, U., Holler, E., Renteria, A. S., Major-Monfried, H., Reddy, P., Aziz, M., Hogan, W. J., Ayuk, F., Efebera, Y. A., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.124015 · Cited by 202
Hoshino, K., Kashiwamura, S.-I., Kuribayashi, K., Kodama, T., Tsujimura, T., Nakanishi, K., Matsuyama, T., Takeda, K., & Akira, S. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1541 · Cited by 201
IL‐33 synergizes with TCR and IL‐12 signaling to promote the effector function of CD8+ T cells
Yang, Q., Li, G., Zhu, Y., Liu, L., Chen, E., Turnquist, H., Zhang, X., Finn, O. J., Chen, X., & Lu, B. (2011) · European Journal of Immunology · doi:10.1002/eji.201141629 · Cited by 199
The role of IL‐33 and mast cells in allergy and inflammation
Saluja, R., Khan, M., Church, M. K., & Maurer, M. (2015) · Clinical and Translational Allergy · doi:10.1186/s13601-015-0076-5 · Cited by 197
Han, J. M., Wu, D., Denroche, H. C., Yao, Y., Verchere, C. B., & Levings, M. K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500020 · Cited by 193
Th9 cells, new players in adaptive immunity
Schmitt, E., Klein, M., & Bopp, T. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.004 · Cited by 189
Duan, L., Chen, J., Zhang, H., Yang, H., Zhu, P., Xiong, A., Xia, Q., Zheng, F., Tan, Z., Gong, F., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00428 · Cited by 183
Holmén, N., Lundgren, A., Lundin, S., Bergin, A.-M., Rudin, A., Sjövall, H., & Öhman, L. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200606000-00003 · Cited by 183
IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes
Wood, I. S., Wang, B., & Trayhurn, P. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.081 · Cited by 182
IL-33 in T Cell Differentiation, Function, and Immune Homeostasis
Peine, M., Marek, R. M., & Löhning, M. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.03.007 · Cited by 179
Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1
Spooner, C. J., Lesch, J., Yan, D., Khan, A. A., Abbas, A., Ramirez-Carrozzi, V., Zhou, M., Soriano, R., Eastham-Anderson, J., Diehl, L., et al. (2013) · Nature Immunology · doi:10.1038/ni.2743 · Cited by 176
TH9 cells are required for tissue mast cell accumulation during allergic inflammation
Sehra, S., Yao, W., Nguyen, E. T., Glosson-Byers, N. L., Akhtar, N., Zhou, B., & Kaplan, M. H. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.021 · Cited by 175
Sattler, S., Ling, G.-S., Xu, D., Hussaarts, L., Romaine, A., Zhao, H., Fossati-Jimack, L., Malik, T., Cook, H. T., Botto, M., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.01.032 · Cited by 173
Role of Mast Cells and Basophils in IgE Responses and in Allergic Airway Hyperresponsiveness
Sawaguchi, M., Tanaka, S., Nakatani, Y., Harada, Y., Mukai, K., Matsunaga, Y., Ishiwata, K., Oboki, K., Kambayashi, T., Watanabe, N., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101746 · Cited by 173
Nygaard, U., Hvid, M., Johansen, C., Buchner, M., Fölster‐Holst, R., Deleuran, M. S., & Vestergaard, C. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13679 · Cited by 172
The IL-33/ST2 axis augments effector T-cell responses during acute GVHD
Reichenbach, D. K., Schwarze, V., Matta, B. M., Tkachev, V., Lieberknecht, E., Liu, Q., Koehn, B. H., Pfeifer, D., Taylor, P. A., Prinz, G., et al. (2015) · Blood · doi:10.1182/blood-2014-10-606830 · Cited by 170
The Increase in Serum Soluble ST2 Protein Upon Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Tajima, S., Oshikawa, K., Tominaga, S.-I., & Sugiyama, Y. (2003) · Chest · doi:10.1378/chest.124.4.1206 · Cited by 169
Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation
Bessa, J., Meyer, C. A., de Vera Mudry, M. C., Schlicht, S., Smith, S. H., Iglesias, A., & Cote-Sierra, J. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.02.012 · Cited by 169
Bulek, K., Swaidani, S., Qin, J., Lu, Y., Gulen, M. F., Herjan, T., Min, B., Kastelein, R. A., Aronica, M., Kosz-Vnenchak, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802729 · Cited by 168
A Novel Therapy of Murine Collagen-Induced Arthritis with Soluble T1/ST2
Leung, B. P., Xu, D., Culshaw, S., McInnes, I. B., & Liew, F. Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.145 · Cited by 168
IL‐33 induces skin inflammation with mast cell and neutrophil activation
Hueber, A. J., Alves‐Filho, J. C., Asquith, D. L., Michels, C., Millar, N. L., Reilly, J. H., Graham, G. J., Liew, F. Y., Miller, A. M., & McInnes, I. B. (2011) · European Journal of Immunology · doi:10.1002/eji.201041360 · Cited by 167
Zeyda, M., Wernly, B., Demyanets, S., Kaun, C., Hämmerle, M., Hantusch, B., Schranz, M., Neuhofer, A., Itariu, B. K., Keck, M., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.118 · Cited by 164
Zhang, J., Ramadan, A. M., Griesenauer, B., Li, W., Turner, M. J., Liu, C., Kapur, R., Hanenberg, H., Blazar, B. R., Tawara, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0166 · Cited by 159
Self-citationEspinassous, Q., Paco, E. G. D., García-Verdugo, I., Synguélakis, M., von Aulock, S., Sallenave, J., McKenzie, A. N. J., & Kanellopoulos, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803067 · Cited by 158
Paczesny, S., Hakim, F. T., Pidala, J., Cooke, K. R., Lathrop, J. T., Griffith, L. M., Hansen, J. A., Jagasia, M., Miklos, D. B., Pavletic, S. Z., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.01.003 · Cited by 155
Self-citationIncreased IL-33 expression in chronic obstructive pulmonary disease
Xia, J., Zhao, J., Shang, J., Li, M., Zeng, Z., Zhao, J., Wang, J., Xu, Y., & Xie, J. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00305.2014 · Cited by 153
Zhao, J., Wei, J., Mialki, R. K., Mallampalli, D., Chen, B. B., Coon, T. A., Zou, C., Mallampalli, R. K., & Zhao, Y. (2012) · Nature Immunology · doi:10.1038/ni.2341 · Cited by 152
Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages
Joshi, A., Oak, S. R., Hartigan, A. J., Finn, W. G., Kunkel, S. L., Duffy, K. E., Das, A., & Hogaboam, C. M. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-52 · Cited by 150
Komai‐Koma, M., Brombacher, F., Pushparaj, P. N., Arendse, B., McSharry, C. P., Alexander, J. K., Chaudhuri, R., Thomson, N. C., McKenzie, A. N. J., McInnes, I. B., et al. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02859.x · Cited by 147
Biomarker Panel for Chronic Graft-Versus-Host Disease
Yu, J., Storer, B. E., Kushekhar, K., Zaid, M. I. A., Zhang, Q., Gafken, P. R., Ogata, Y., Martin, P. J., Flowers, M. E. D., Hansen, J. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.9615 · Cited by 146
Self-citationA Novel Cardiac Bio-Marker: ST2: A Review
Ciccone, M. M., Cortese, F., Gesualdo, M., Riccardi, R., Nunzio, D. D., Moncelli, M., Iacoviello, M., & Scicchitano, P. (2013) · Molecules · doi:10.3390/molecules181215314 · Cited by 144
Primary sources and immunological prerequisites for sST2 secretion in humans
Mildner, M., Storka, A., Lichtenauer, M., Mlitz, V., Ghannadan, M., Höetzenecker, K., Nickl, S., Döme, B., Tschachler, E., & Ankersmit, H. J. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq104 · Cited by 142
Expression and function of the ST2 gene in a murine model of allergic airway inflammation
Oshikawa, K., Yanagisawa, K., Tominaga, S.-I., et al. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2745.2002.01494.x · Cited by 142
TRAF6 is a critical signal transducer in IL-33 signaling pathway
Funakoshi‐Tago, M., Tago, K., Hayakawa, M., Tominaga, S., Ohshio, T., Sonoda, Y., & Kasahara, T. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.05.013 · Cited by 141
Jones, L. A., Roberts, F., Nickdel, M. B., Brombacher, F., McKenzie, A. N. J., Henriquez, F. L., Alexander, J. K., & Roberts, C. W. (2009) · European Journal of Immunology · doi:10.1002/eji.200939705 · Cited by 138
Louten, J., Rankin, A. L., Li, Y., Murphy, E. E., Beaumont, M., Moon, C., Bourne, P. A., McClanahan, T. K., Pflanz, S., & Malefyt, R. D. W. (2011) · International Immunology · doi:10.1093/intimm/dxr006 · Cited by 136
Matta, B. M., Reichenbach, D. K., Zhang, X., Mathews, L. R., Koehn, B. H., Dwyer, G. K., Lott, J. M., Uhl, F. M., Pfeifer, D., Feser, C. J., et al. (2016) · Blood · doi:10.1182/blood-2015-12-684142 · Cited by 132
Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma
Lee, H., Rhee, C. K., Kang, J. Y., Byun, J. H., Choi, J. Y., Kim, S. J., Kim, Y. K., Kwon, S. S., & Lee, S. Y. (2014) · Experimental Lung Research · doi:10.3109/01902148.2013.870261 · Cited by 129
Ponce, D. M., Hilden, P. D., Mumaw, C. L., Devlin, S. M., Lubin, M. N., Giralt, S. A., Goldberg, J. D., Hanash, A. M., Hsu, K. C., Jenq, R. R., et al. (2014) · Blood · doi:10.1182/blood-2014-06-584789 · Cited by 125
Self-citationWaern, I., Lundequist, A., Pejler, G., & Wernersson, S. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.129 · Cited by 122
IL-33 Activates B1 Cells and Exacerbates Contact Sensitivity
Komai‐Koma, M., Gilchrist, D. S., McKenzie, A. N. J., Goodyear, C. S., Xu, D., & Liew, F. Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002103 · Cited by 121
Tago, K., Noda, T., Hayakawa, M., Iwahana, H., Yanagisawa, K., Yashiro, T., & Tominaga, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5306 · Cited by 121
Emerging role of interleukin‐33 in autoimmune diseases
Pei, C., Barbour, M., Fairlie‐Clarke, K. J., Allan, D., Mu, R., & Jiang, H. (2013) · Immunology · doi:10.1111/imm.12174 · Cited by 111
Li, M., Li, Y., Liu, X., Gao, X., & Wang, Y. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.016 · Cited by 111
IL-33 attenuates development and perpetuation of chronic intestinal inflammation
Gro, P., Doser, K., Falk, W., Obermeier, F., & Hofmann, C. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22900 · Cited by 110
IL-33 Induces IL-9 Production in Human CD4+ T Cells and Basophils
Blom, L. H., Poulsen, B. C., Jensen, B. M., Hansen, A., & Poulsen, L. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021695 · Cited by 108
Induction of a Mitogen-Responsive Gene after Expression of the Ha-rasOncogene in NIH 3T3 Fibroblasts
Werenskiold, A. K., Hoffmann, S., & Klemenz, R. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.11.5207-5214.1989 · Cited by 107
Interleukin-33 prolongs allograft survival during chronic cardiac rejection
Brunner, S. M., Schiechl, G., Falk, W., Schlitt, H. J., Geissler, E. K., & Fichtner‐Feigl, S. (2011) · Transplant International · doi:10.1111/j.1432-2277.2011.01306.x · Cited by 105
Meisel, C., Bonhagen, K., Löhning, M., Coyle, A., Gutiérrez-Ramos, J., Radbruch, A., & Kamradt, T. (2001) · Journal of Immunology · doi:10.4049/jimmunol.166.5.3143 · Cited by 104
Gächter, T., Werenskiold, A. K., & Klemenz, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.124 · Cited by 101
Activated mast cells synthesize and release soluble ST2‐a decoy receptor for IL‐33
Bandara, G., Beaven, M. A., Olivera, A., Gilfillan, A. M., & Metcalfe, D. D. (2015) · European Journal of Immunology · doi:10.1002/eji.201545501 · Cited by 100
Nabekura, T., Girard, J., & Lanier, L. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500424 · Cited by 96
Fragale, A., Gabriele, L., Stellacci, E., Borghi, P., Perrotti, E., Ilari, R., Lanciotti, A., Remoli, A. L., Venditti, M., Belardelli, F., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1673 · Cited by 94
de Andrade, M. V. M., Iwaki, S., Ropert, C., Gazzinelli, R. T., Cunha-Melo, J. R., & Beaven, M. A. (2011) · European Journal of Immunology · doi:10.1002/eji.201040718 · Cited by 93
IL-33/ST2 axis promotes mast cell survival via BCLXL
Wang, J., Kaieda, S., Ameri, S., Fishgal, N., Dwyer, D. F., Dellinger, A. L., Kepley, C. L., Gurish, M. F., & Nigrovic, P. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404182111 · Cited by 92
Su, Z., Lin, J., Lü, F., Zhang, X., Zhang, L., Gandhi, N. B., de Paiva, C. S., Pflugfelder, S. C., & Li, D.-Q. (2013) · Mucosal Immunology · doi:10.1038/mi.2012.130 · Cited by 85
Soluble ST2 Levels Are Associated with Bleeding in Patients with Severe Leptospirosis
Wagenaar, J. F. P., Gasem, M. H., Goris, M. G. A., Leeflang, M., Hartskeerl, R. A., van der Poll, T., Veer, C. V. ′., & Gorp, E. C. M. V. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000453 · Cited by 83
Shao, D., Perros, F., Caramori, G., Meng, C., Dormuller, P., Chou, P.-C., Church, C., Papi, A. A., Casolari, P., Welsh, D., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.111 · Cited by 83
IL-33 induces Th17-mediated airway inflammation via mast cells in ovalbumin-challenged mice
Cho, K., Suh, J. W., Sohn, J.-H., Park, J., Lee, H., Kang, J. L., Woo, S., & Cho, Y.-J. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00252.2011 · Cited by 83
Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09
Bradley-Stewart, A., Jolly, L., Adamson, W. E., Gunson, R. N., Frew-Gillespie, C., Templeton, K. E., Aitken, C., Carman, W. F., Cameron, S. O., & McSharry, C. P. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.05.011 · Cited by 80
Andersson, C., Preis, S. R., Beiser, A., DeCarli, C. S., Wollert, K. C., Wang, T. J., Januzzi, J. L., Vasan, R. S., & Seshadri, S. S. (2015) · Stroke · doi:10.1161/strokeaha.115.009026 · Cited by 79
IL-1β-Driven ST2L Expression Promotes Maturation Resistance in Rapamycin-Conditioned Dendritic Cells
Turnquist, H. R., Sumpter, T. L., Tsung, A., Zahorchak, A. F., Nakao, A., Nau, G. J., Liew, F. Y., Geller, D. A., & Thomson, A. W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.62 · Cited by 78
IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis
Wu, B., Huang, C., Kato‐Maeda, M., Hopewell, P. C., Daley, C. L., Krensky, A. M., & Clayberger, C. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.09.009 · Cited by 71
Interleukin-33 promoting Th1 lymphocyte differentiation dependents on IL-12
Komai‐Koma, M., Wang, E., Kurowska‐Stolarska, M., Li, D., McSharry, C. P., & Xu, D. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.11.013 · Cited by 68
Miller, A. M., Purves, D. G., McConnachie, A., Asquith, D. L., Batty, G. D., Burns, H., Cavanagh, J., Ford, I., McLean, J. S., Packard, C. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047830 · Cited by 66
Lal, G., Yin, N., Xu, J., Lin, M., Schroppel, S., Ding, Y., Marie, I., Levy, D. E., & Bromberg, J. S. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03389.x · Cited by 64
Molecular cloning of the chicken ST2 gene and a novel variant form of the ST2 gene product, ST2LV
Iwahana, H., Hayakawa, M., Kuroiwa, K., Tago, K., Yanagisawa, K., Noji, S., & Tominaga, S. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.08.013 · Cited by 61
ST2 Is Essential for Th2 Responsiveness and Resistance to Pseudomonas aeruginosa Keratitis
Huang, X., Du, W., Barrett, R. P., & Hazlett, L. D. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0316 · Cited by 61
Interleukin-33 affects cytokine production by keratinocytes in vitiligo
Li, P.-F., Ma, H., Han, D., & Mou, K. (2014) · Clinical and Experimental Dermatology · doi:10.1111/ced.12464 · Cited by 58
Bajwa, E. K., Volk, J., Christiani, D. C., Harris, R. S., Matthay, M. A., Thompson, B., & Januzzi, J. L. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182978f91 · Cited by 53
Vasanthakumar, A., Moro, K., Xin, A., Liao, Y., Gloury, R., Kawamoto, S., Fagarasan, S., Mielke, L. A., Afshar‐Sterle, S., Masters, S. L., et al. (2015) · Nature Immunology · doi:10.1038/ni0515-544d · Cited by 48
Yang, Z., Sun, R., Grinchuk, V., Fernández-Blanco, J. A., Notari, L., Bohl, J. A., McLean, L. P., Ramalingam, T. R., Wynn, T. A., Urban, J. F., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00357.2012 · Cited by 42
Gajardo, T., Morales, R. A., Campos‐Mora, M., Campos‐Acuña, J., & Pino‐Lagos, K. (2015) · Immunology · doi:10.1111/imm.12483 · Cited by 41
The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection
Mehraj, V., Jenabian, M.-A., Ponte, R., Lebouché, B., Costiniuk, C. T., Thomas, R., Baril, J.-G., LeBlanc, R. P., Cox, J., Tremblay, C. L., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001105 · Cited by 40
Kanakry, C. G., Bakoyannis, G., Perkins, S. M., McCurdy, S. R., Vulic, A., Warren, E. H., Daguindau, É., Olmsted, T., Mumaw, C. L., Towlerton, A. M. H., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.152322 · Cited by 38
Self-citationSoluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
Díaz-Jiménez, D., la Fuente, M. D., Dubois‐Camacho, K., Landskron, G., Fuentes, J., Pérez-Jeldres, T., González, M. J., Simian, D., Hermoso, M. A., & Quera, R. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0520-6 · Cited by 37
A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis Skin
Rice, L. M., Mantero, J. C., Stifano, G., Ziemek, J., Simms, R. W., Gordon, J., Domsic, R. T., & Lafyatis, R. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.08.027 · Cited by 34
T1/ST2 promotes T helper 2 cell activation and polyfunctionality in bronchopulmonary mycosis
Piehler, D., Grahnert, A., Eschke, M., Richter, T., Köhler, G., Stenzel, W., & Alber, G. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.84 · Cited by 32
High plasma sST2 levels in gastric cancer and their association with metastatic disease
Bergis, D., Kassis, V., & Radeke, H. H. (2016) · Cancer Biomarkers · doi:10.3233/cbm-150547 · Cited by 30
Matsuki, A., Takatori, H., Makita, S., Yokota, M., Tamachi, T., Suto, A., Suzuki, K., Hirose, K., & Nakajima, H. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.022 · Cited by 28
Zhao, J., Chen, Q., Li, H., Myerburg, M. M., Spannhake, E. W., Natarajan, V., & Zhao, Y. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.08.004 · Cited by 26
Involvement of PU.1 in Mast Cell/Basophil-Specific Function of the Human IL1RL1/ST2 Promoter
Baba, Y., Maeda, K., Yashiro, T., Inage, E., Niyonsaba, F., Hara, M., Suzuki, R., Ohtsuka, Y., Shimizu, T., Ogawa, H., et al. (2012) · Allergology International · doi:10.2332/allergolint.12-oa-0424 · Cited by 25
Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells
Nagata, A., Takezako, N., Tamemoto, H., Ohto‐Ozaki, H., Ohta, S., Tominaga, S., & Yanagisawa, K. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2012.29 · Cited by 25
Soluble ST2 Plasma Concentrations Predict Mortality in HBV‐Related Acute‐on‐Chronic Liver Failure
Lei, Z., Mo, Z., Zhu, J., Pang, X., Zheng, X., Wu, Z.-B., Wang, K., Li, X., Xie, D., & Gao, Z. (2015) · Mediators of Inflammation · doi:10.1155/2015/535938 · Cited by 25
Impact of IL -9 and IL-33 in mast cells.
Sabatino, G., Nicoletti, M., Neri, G., Saggini, A., Rosati, M., Conti, F., Cianchetti, E., Toniato, E., Fulcheri, M., Caraffa, A., et al. (2012) · PubMed · Cited by 24
Potential role of the IL-33/ST2 axis in celiac disease
López-Casado, M. A., Lorite, P., Palomeque, T., & Torres, M. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.85 · Cited by 22
Putting the brakes on ILC2 cells
Stehle, C., Saikali, P., & Romagnani, C. (2015) · Nature Immunology · doi:10.1038/ni.3353 · Cited by 19
sST2 translation is regulated by FGF2 via an hnRNP A1-mediated IRES-dependent mechanism
Kunze, M. M., Benz, F., Brauß, T. F., Lampe, S., Weigand, J. E., Braun, J., Richter, F. M., Wittig, I., Brüne, B., & Schmid, T. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.05.005 · Cited by 18
Soluble ST2 Levels and Left Ventricular Structure and Function in Patients With Metabolic Syndrome
Celic, V. P., Majstorovic, A., Pencic, B. D., Šljivić, A., López‐Andrés, N., Roy, I., Escribano, E., Beunza, M., Melero, A., Floridi, F., et al. (2016) · Annals of Laboratory Medicine · doi:10.3343/alm.2016.36.6.542 · Cited by 18
Johnpulle, R. A. N., Paczesny, S., Jung, D. K., Daguindau, É., Jagasia, M., Savani, B. N., Chinratanalab, W., Cornell, R. F., Goodman, S. A., Greer, J. P., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.12.627 · Cited by 17
Self-citationTrüb, T., Kalousek, M. B., Fröhli, E., & Klemenz, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3896 · Cited by 16
Application of Biomarkers to Clinical Trials in Systemic Sclerosis
Lafyatis, R. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0216-4 · Cited by 16
Research works printed but not linked: 10
- Tominaga, 2016, Soluble form of the ST2 gene product exhibits growth promoting activity in NIH-3T3 cells, Biochem Biophys Rep, 5, 8, 10.1016/j.bbrep.2015.11.020 · doi:10.1016/j.bbrep.2015.11.020
- Caselli, 2014, Inflammation in cardiac disease: focus on Interleukin-33/ST2 pathway, Inflamm Cell Signal, 1, e149, 10.14800/ics.149 · doi:10.14800/ics.149
- Diaz-Jimenez, 2011, Soluble ST2: a new and promising activity marker in ulcerative colitis, World J Gastroenterol, 17, 2181, 10.3748/wjg.v17.i17.2181 · doi:10.3748/wjg.v17.i17.2181
- McDonald, 2015, Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment, Blood, 126, 113, 10.1182/blood-2015-03-636753 · doi:10.1182/blood-2015-03-636753
- Abu Zaid, 2017, Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT, Blood, 129, 162, 10.1182/blood-2016-08-735324 · doi:10.1182/blood-2016-08-735324
- Mathews, 2016, Elevated ST2 distinguishes incidences of pediatric heart and small bowel transplant rejection, Am J Transplant, 16, 938, 10.1111/ajt.13542 · doi:10.1111/ajt.13542
- Lin, 2016, Distribution and clinical association of plasma soluble ST2 during the development of type 2 diabetes, Diabetes Res Clin Pract, 118, 140, 10.1016/j.diabres.2016.06.006 · doi:10.1016/j.diabres.2016.06.006
- Thomassen, 1995, Role of cell type-specific promoters in the developmental regulation of T1, an interleukin 1 receptor homologue, Cell Growth Differ, 6, 179
- Na, 2012, IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils, Cytokine, 57, 169, 10.1016/j.cyto.2011.10.007 · doi:10.1016/j.cyto.2011.10.007
- Seo, 2016, Biomarkers for idiopathic pneumonia syndrome (IPS) after hematopoietic cell transplantation (HCT): comparison with viral infectious pneumonia, Biol Blood Marrow Transplant, 22, S73, 10.1016/j.bbmt.2015.11.366 · doi:10.1016/j.bbmt.2015.11.366
Cited by
The Immunopathophysiology of Endometriosis
Symons, L. K., Miller, J. E., Kay, V. R., Marks, R. M., Liblik, K., Koti, M., & Tayade, C. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.07.004 · Cited by 567
Cardoso, A. L., Fernandes, A., Aguilar-Pimentel, J. A., de Angelis, M. H., Guedes, J. R., Brito, M. A., Ortolano, S., Pani, G., Athanasopoulou, S., Gonos, E. S., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.004 · Cited by 475
The family of the interleukin‐1 receptors
Boraschi, D., Italiani, P., Weil, S., & Martin, M. U. (2018) · Immunological Reviews · doi:10.1111/imr.12606 · Cited by 389
Adaptive immunity: an emerging player in the progression of NAFLD
Sutti, S., & Albano, E. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0210-2 · Cited by 374
An immune-based biomarker signature is associated with mortality in COVID-19 patients
Abers, M. S., Delmonte, O. M., Ricotta, E. E., Fintzi, J., Fink, D. L., de Jesus, A. A. A., Zarember, K. A., Alehashemi, S., Oikonomou, V., Desai, J. V., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.144455 · Cited by 340
Metadata
- Authors
- Griesenauer, B., & Paczesny, S.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-04-24
- Volume
- 8
- Pages
- 475-475
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2609744794
- Cited by
- 619
- References
- 192
- FWCI
- 18.84
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Cancer Institute (R01CA168814)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007519)
- Leukemia and Lymphoma Society (1293-15)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.